Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP267408.RAwA-Vdvbsl_HKqFnIfszl0SgHBVZ5LQ8sX1r0zI7s9FI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP267408.RAwA-Vdvbsl_HKqFnIfszl0SgHBVZ5LQ8sX1r0zI7s9FI130_assertion type Assertion NP267408.RAwA-Vdvbsl_HKqFnIfszl0SgHBVZ5LQ8sX1r0zI7s9FI130_head.
- NP267408.RAwA-Vdvbsl_HKqFnIfszl0SgHBVZ5LQ8sX1r0zI7s9FI130_assertion description "[We demonstrate here that BGP-13, a new calcipotriene-based 1?,25-dihydroxyvitamin D3 analog that we synthesized in our laboratory, inhibits the growth of prostate cancer (LNCaP), breast cancer (MCF-7), and colon cancer (HT-29) cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP267408.RAwA-Vdvbsl_HKqFnIfszl0SgHBVZ5LQ8sX1r0zI7s9FI130_provenance.
- NP267408.RAwA-Vdvbsl_HKqFnIfszl0SgHBVZ5LQ8sX1r0zI7s9FI130_assertion evidence source_evidence_literature NP267408.RAwA-Vdvbsl_HKqFnIfszl0SgHBVZ5LQ8sX1r0zI7s9FI130_provenance.
- NP267408.RAwA-Vdvbsl_HKqFnIfszl0SgHBVZ5LQ8sX1r0zI7s9FI130_assertion SIO_000772 22661288 NP267408.RAwA-Vdvbsl_HKqFnIfszl0SgHBVZ5LQ8sX1r0zI7s9FI130_provenance.
- NP267408.RAwA-Vdvbsl_HKqFnIfszl0SgHBVZ5LQ8sX1r0zI7s9FI130_assertion wasDerivedFrom befree-20150227 NP267408.RAwA-Vdvbsl_HKqFnIfszl0SgHBVZ5LQ8sX1r0zI7s9FI130_provenance.
- NP267408.RAwA-Vdvbsl_HKqFnIfszl0SgHBVZ5LQ8sX1r0zI7s9FI130_assertion wasGeneratedBy ECO_0000203 NP267408.RAwA-Vdvbsl_HKqFnIfszl0SgHBVZ5LQ8sX1r0zI7s9FI130_provenance.